Impaired glutamate uptake in the R6 Huntington's disease transgenic mice

Neurobiology of Disease

Volumn 8, Issue 5, 2001, Pages 807-821

  Lievens J C ^a   Woodman, B ^a   Mahal, A ^a   Spasic Boscovic, O ^a   Samuel, D ^b   Kerkerian Le Goff, L ^b   Bates, G P ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUTAMATE AMMONIA LIGASE; GLUTAMIC ACID; MESSENGER RNA; POLYCLONAL ANTIBODY; POLYGLUTAMINE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; DNA PROBE; GENE EXPRESSION; GENE MUTATION; HUNTINGTON CHOREA; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MACROGLIA; MOUSE; NERVE CELL NECROSIS; NEUROLOGIC DISEASE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; TRANSGENIC MOUSE; TRINUCLEOTIDE REPEAT;

EID: 0035164743     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1006/nbdi.2001.0430     Document Type: Article

References (68)

1. Changes of NMDA receptor subunit (NR1, NR2B) and glutamate transporter (GLT1) mRNA expression in Huntington's disease - An in situ hybridization study
2. Functional comparisons of three glutamate transporter subtypes cloned from human motor cortex
3. Reduction in enkephalin and substance P messenger RNA in the striatum of early grade Huntington's disease: A detailed cellular in situ hybridization study
4. Intranuclear neuronal inclusions in Huntington's disease and dentatorubral and pallidoluysian atrophy: Correlation between the density of inclusions and IT15 CAG triplet repeat
5. Comparative analysis of glutamate transporter expression in rat brain using differential double in situ hybridization
6. Severe deficiencies in dopamine signaling in presymptomatic Huntington's disease mice
7. Characterization of progressive motor deficits in mice transgenic for the human Huntington's disease mutation
8. Transcriptional dysregulation in Huntington's disease
9. Altered neurotransmitter receptor expression in transgenic mouse models of Huntington's disease
10. Altered brain neurotransmitter receptors in transgenic mice expressing a portion of an abnormal human huntington disease gene
11. EAAC1, a high-affinity glutamate transporter, is localized to astrocytes and gabaergic neurons besides pyramidal cells in the rat cerebral cortex
12. Reduced high-affinity glutamate uptake sites in the brains of patients with Huntington's disease
13. The high affinity uptake system for excitatory amino acids in the brain
14. Sodium- and potassium-dependent excitatory amino acid transporters in brain plasma membranes
15. Properties and localization of glutamate transporters
16. Localization of transporters using transporter-specific antibodies
17. Na+ dependent binding of D-aspartate in brain membranes is largely due to uptake into membrane-bounded saccules
18. Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation
19. Morphometric demonstration of atrophic changes in the cerebral cortex, white matter, and neostriatum in Huntington's disease
20. Cannabinoid receptor messenger RNA levels decrease in a subset of neurons of the lateral striatum, cortex and hippocampus of transgenic Huntington's disease mice
21. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain
22. The pattern of neurodegeneration in Huntington's disease: A comparative study of cannabinoid, dopamine, adenosine and GABA(A) receptor alterations in the human basal ganglia in Huntington's disease
23. Nuclear and neuropil aggregates in Huntington's disease: Relationship to neuropathology
24. Transgenic mice expressing a Huntington's disease mutation are resistant to quinolinic acid-induced striatal excitotoxicity
25. Brain glutamate transporter proteins form homomultimers
26. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes
27. A YAC mouse model for Huntington's disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration
28. Mouse excitatory amino acid transporter EAAT2: Isolation, characterization, and proximity to neuroexcitability loci on mouse chromosome 2
29. Differentiation of substrate and nonsubstrate inhibitor of the high-affinity, sodium-dependent glutamate transporters
30. Glutamate transporter EAAC1 is expressed in neurons and glial cells in the rat nervous system
31. Mouse glutamine synthetase is encoded by a single gene that can be expressed in a localized fashion
32. Differential expression of two glial glutamate transporters in the rat brain: Quantitative and immunocytochemical observations
33. Enhanced sensitivity to N-methyl-D-aspartate receptor activation in transgenic and knockin mouse models of Huntington's disease
34. A monoclonal antibody raised against an [Na(+)+K+]coupled L-glutamate transporter purified from rat brain confirms glial cell localization
35. Ultrastructural localization and progressive formation of neuropil aggregates in Huntington's disease transgenic mice
36. Amino-terminal fragments of mutant huntingtin show selective accumulation in striatal neurons and synaptic toxicity
37. Characterization of striatal lesions produced by glutamate uptake alteration: Cell death, reactive gliosis, and changes in GLT1 and GADD45 mRNA expression
38. Decreased expression of striatal signaling genes in a mouse model of Huntington's disease
39. Characterisation of glutamate transport in astrocytes cultured from EAAT2 transgenic mice
40. Instability of highly expanded CAG repeats in mice transgenic for the Huntington's disease mutation
41. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice
42. Accumulation of extracellular glutamate by inhibition of its uptake is not sufficient for inducing neuronal damage: An in vivo microdialysis study
43. Decrease in striatal enkephalin mRNA in mouse models of Huntington's disease
44. Huntington's disease
45. Distribution of messenger RNAs encoding the enzymes glutaminase, aspartate aminotransferase and glutamic acid decarboxylase in rat brain
46. Altered striatal amino acid neurotransmitter release monitored using microdialysis in R6/1 Huntington transgenic mice
47. Cloning and expression of a rat brain L-glutamate transporter
48. Antisense knockdown of the glial glutamate transporter GLT-1 exacerbates hippocampal neuronal damage following traumatic injury to rat brain
49. Antisense knockout of glial glutamate transporter GLT1 exacerbates ischemic neuronal damage
50. Behavioural abnormalities and selective neuronal loss in HD transgenic mice expressing mutated full-length HD cDNA
51. Transient inhibition of glutamate uptake in vivo induces neurodegeneration when energy metabolism is impaired
52. Huntingtin-encoded polyglutamine expansions form amyloid-like protein aggregates in vitro and in vivo
53. Self-assembly of polyglutamine-containing huntingtin fragments into amyloid-like fibrils: Implications for Huntington's disease pathology
54. Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin
55. Expression of the glutamate transporter GLT1 in neural cells of the rat central nervous system: Non-radioactive in situ hybridization and comparative immunocytochemistry
56. Cellular and regional distribution of the glutamate transporter GLAST in the CNS of rats: Nonradioactive in situ hybridization and comparative immunocytochemistry
57. Structure, expression, and functional analysis of a Na(+)-dependent glutamate/aspartate transporter from rat brain
58. Glutamic acid and excitatory nerve endings: Reduction of glutamic acid uptake after axotomy
59. Glutamate transporter mRNA expression in proliferative zones of the developing and adult murine CNS
60. Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1
61. Differential distribution of the glutamate transporters GLT1 and rEAAC1 in rat cerebral cortex and thalamus: An in situ hybridization analysis
62. Nonapoptotic neurodegeneration in a transgenic mouse model of Huntington's disease
63. Neuropathological classification of Huntington's disease
64. Striatal D1 and D2 dopamine receptor loss in asymptomatic mutation carriers of Huntington's disease
65. Long glutamine tracts cause nuclear localization of a novel form of huntingtin in medium spiny striatal neurons in HdhQ92 and HdhQ111 knock-in mice
66. Brain glutamate metabolism: Neuronal-astroglial relationships
67. Epidermal growth factor receptor agonists increase expression of glutamate transporter GLT-1 in astrocytes through pathways dependent on phosphatidylinositol 3-kinase and transcription factor NF-kappaB